Unlocking precision: The role of PROCIPIENT® (Dimethyl Sulfoxide USP, Ph. Eur.) in Antibody drug conjugate manufacturing

Are hidden solvent choices slowing down your ADC programs? Join our webinar to discover how the right solvent grade system, like GMP-produced PROCIPIENT® can unlock higher conjugation efficiency, smoother regulatory pathways, and better patient outcomes.

Register Free: https://www.pharmtech.com/pt_w/unlocking-precision

Event Overview:

In antibody-drug conjugate (ADC) manufacturing, solvent choice is far more important than a background detail. It directly impacts conjugation efficiency, stability, and regulatory approval. Unlike technical-grade alternatives, PROCIPIENT^® (dimethyl sulfoxide USP, Ph Eur) is the only GMP-produced DMSO designed specifically for parenteral use, giving formulators confidence in both purity and compliance. This webinar will explore how choosing the right solvent grade system can accelerate ADC development, lower hidden costs, and create a competitive advantage in complex drug delivery.

Key Learning Objectives:

• Optimize ADCs with a GMP-grade solvent system
• Mitigate risks from impurities in conjugation
• Leverage PROCIPIENT^® (dimethyl sulfoxide USP, Ph Eur) for regulatory success

Who Should Attend:

• Formulation scientists/biopharmaceutics scientists developing ADC formulations
• Process development scientists and engineers scaling conjugation processes

Speaker:

Rishi Pimentel
Global Business Development Director, Life Sciences
gChem

Rishi Pimentel serves as the global business development director, life sciences, at gChem. He leads the global strategy, market development, and expansion with a focus on excipients and complex drug delivery. With deep expertise across biopharma, injectables, and cell and gene therapies, Pimentel drives growth by aligning innovation, regulatory integrity, and market focus outcomes

Register Free: https://www.pharmtech.com/pt_w/unlocking-precision